Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test
June 18, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
March 21, 2019 08:30 ET
|
Daxor Corporation
Author incorrectly claimed, “The company's sole product is a blood volume analyzer called the BVA-100 but there does not appear to be any sales to date.” NEW YORK, March 21, 2019 (GLOBE NEWSWIRE)...
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress
February 13, 2019 08:30 ET
|
Daxor Corporation
New Research Abstracts Scheduled for Presentation on Daxor’s BVA-100® NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical...
Daxor Corporation Announces Acquisition of BVA-100® Blood Volume Analyzer to Aspirus Wausau Hospital in Wisconsin
January 10, 2019 08:30 ET
|
Daxor Corporation
NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...